Anika Therapeutics Inc (ANIK) stock news · rev $112.8M
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
This ANIK news page leads with what Anika Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for ANIK yet. We will not pad this page with generic market recap.
Latest reported ANIK revenue for 2025-12-31 was $112.8M. Net income was -$10.9M. Revenue was down 5.9% from 2024-12-31 to 2025-12-31. ANIK currently screens at market cap $161.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ANIK stock page; for the tape open the quote page.
ANIK stock news FAQ
What are ANIK's latest revenue and net income?
Latest cached Anika Therapeutics Inc (ANIK) revenue for Dec 31, 2025 was $112.8M. Net income was -$10.9M. Statements: https://lician.com/financials/anik
How did ANIK revenue change from the prior cached period?
Cached Anika Therapeutics Inc (ANIK) revenue was down 5.9% from $119.9M (Dec 31, 2024) to $112.8M (Dec 31, 2025). Statements: https://lician.com/financials/anik
What is ANIK's market cap?
Anika Therapeutics Inc (ANIK) market cap is $161.3M on the latest cached fundamentals snapshot.
What kind of company is ANIK?
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Where is ANIK stock news listed?
Cached stock news for Anika Therapeutics Inc (ANIK) is listed at https://lician.com/news/anik. Filings: https://lician.com/sec/anik
Not investment advice.